High titers of autoantibodies targeting MOG are identified in various demyelinating diseases, including optic neuritis, transverse myelitis, acute disseminated encephalomyelitis (ADEM), and cerebral cortical encephalitis. The gene discussed is MOG; the disease is optic neuritis.